Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes

It has been suggested that reactive oxygen species released by activated polymorphonuclear leukocytes (PMN) in man is one mechanism of tissue injury. Therapeutic action aimed at increasing antioxidant defence mechanisms is still a clinical challenge. This study examines the activity of N-acetylcysteine, a known antioxidant, in the protection of PMN exposed in-vitro to the chemoattractant peptide fMet-Leu-Phe (FMLP), the protein kinase C activator phorbol myristate acetate or the lipid peroxidation promoter t-butyl hydroperoxide. FMLP (3-300 nM) and phorbol myristate acetate (160 pm-160 nM) induced concentration-related superoxide anion generation. Pre-treatment with N-acetylcysteine (33-333 mu M) resulted in concentration-related inhibition of superoxide production induced by FMLP (30 nM) or phorbol myristate acetate (16 nM); -log IC50 values were 3.97 plus or minus 0.07 and 3.91 plus or minus 0.10, respectively. Changes in intracellular calcium ion concentration ([Ca super(2+)] sub(i)) induced by FMLP (30 nM) were studied in fura-2-loaded human PMN. FMLP produced a transient calcium response, i.e. a peak followed by decay to a residual value above baseline. N-Acetylcysteine (333 mu M) did not affect either basal [Ca super(2+)] sub(i) values or changes in [Ca super(2+)] sub(i) values after treatment with FMLP. Activation by phorbol myristate acetate caused a reduction in glutathione levels from 5.94 plus or minus 0.86 (control) to 1.84 plus or minus 0.51 nmol/3 x 10 super(6) cells (P < 0.05 compared with control). Pre-treatment with N-acetylcysteine (333 mu M) fully reversed the reduction in glutathione levels induced by phorbol myristate acetate (4.83 plus or minus 0.68 nmol/3 x 10 super(6) cells; P > 0.05 compared with control). Exposure to t-butyl hydroperoxide (0.5 mM, 30 min) markedly increased malondialdehyde levels (from 0.03 plus or minus 0.02 to 0.73 plus or minus 0.07 nmol/10 super(6) cells), and index of lipid peroxidation. Malondialdehyde levels were significantly reduced in PMN treated with N-acetylcysteine (333 mu M; 0.55 plus or minus 0.04 nmol /10 super(6) cells; P < 0.05 compared with untreated cells exposed to t-butyl hydroperoxide). In conclusion, N-acetylcysteine reduces superoxide generation in response to FMLP and phorbol myristate acetate and partially protects against lipid peroxidation in PMN from man. The protection afforded by N-acetylcysteine is not related to alteration of the intracellular calcium signal but might be effected